Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mosnodenvir for Prevention of Dengue Infection
NCT05201794Phase 2Terminated
- Sponsor
- Janssen Pharmaceutical
- Start
- Feb 2023
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 2 trial of mosnodenvir in dengue fever, sponsored by Janssen Pharmaceutical. Started Feb 2023; status: terminated.
02
Drugs
mosnodenvir
03
Conditions
dengue fever
Beyond the preview
Go deeper on NCT05201794.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05201794.